Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg 2010 May;139(5):1306-15

Date

04/24/2010

Pubmed ID

20412963

DOI

10.1016/j.jtcvs.2010.02.004

Scopus ID

2-s2.0-77950978247 (requires institutional sign-in at Scopus site)   118 Citations

Abstract

OBJECTIVE: We sought to examine long-term outcomes at the University of Wisconsin for all lung transplant recipients who received lungs from donation after cardiac death donors since the initiation of this program in 1993.

METHODS: Eighteen (4.2%) of the 424 lung transplantations performed in 406 patients between January 1993 and April 2009 used lungs from donation after cardiac death donors. Outcomes for this recipient cohort were compared with those for recipients who received organs from brain-dead donors.

RESULTS: Warm ischemic time (from withdrawal of support to reperfusion of organs) was 30 +/- 17 minutes (11-93 minutes). The patient survival rates in the donation after cardiac death group (DCD group) at 1, 3, and 5 years were 88.1% +/- 7.9%, 81.9% +/- 9.5%, and 81.9% +/- 9.5%, respectively. These survival rates were not different from those of the brain-dead donor group (BDD group, P = .66). The incidence of primary graft dysfunction in the DCD group was similar to that of the BDD group (P = .59). However, the incidence of airway complications was somewhat higher in the DCD group. Freedom from bronchiolitis obliterans syndrome at 1, 3, and 5 years in the DCD group was 80.4% +/- 10.2%, 80.4% +/- 10.2%, and 72.3% +/- 11.9%, respectively, and did not differ from the incidence of bronchiolitis obliterans syndrome in the BDD group (P = .59).

CONCLUSIONS: Our data show that the long-term patient and graft survival rates after donation after cardiac death lung transplantation were equivalent to those after brain-dead donor lung transplantation. Our findings suggest that the use of donation after cardiac death donors can safely and substantially expand the donor pool for lung transplantation.

Author List

De Oliveira NC, Osaki S, Maloney JD, Meyer KC, Kohmoto T, D'Alessandro AM, Love RB

Author

Takushi Kohmoto MD, PhD Professor in the Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Bronchiolitis Obliterans
Chi-Square Distribution
Death
Female
Follow-Up Studies
Graft Survival
Humans
Kaplan-Meier Estimate
Lung Transplantation
Male
Middle Aged
Primary Graft Dysfunction
Program Evaluation
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Tissue Donors
Treatment Outcome
Warm Ischemia
Wisconsin